Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 18, 2014 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Submits FDA IND Filing for Noninfectious Anterior Uveitis

LEXINGTON, Mass., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
December 16, 2014 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Abstract Accepted at 2015 American Academy of Allergy Asthma & Immunology Annual Meeting

LEXINGTON, Mass., Dec. 16, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
December 04, 2014 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Announces Collaboration With the National Organization for Rare Disorders to Enhance Awareness for Sjogren-Larsson Syndrome Patients

LEXINGTON, Mass., Dec. 4, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
November 13, 2014 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics to Present at the Therapeutic Area Partnerships Meeting

LEXINGTON, Mass., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
November 10, 2014 08:16 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Reports Third Quarter and Year to Date 2014 Financial Results

LEXINGTON, Mass., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
November 03, 2014 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results

BURLINGTON, Mass., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
September 05, 2014 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics to Present at Upcoming Investor Conferences

BURLINGTON, Mass., Sept. 5, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
September 02, 2014 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Expands Drug Development Team in Advance of NS2 Clinical Trials

BURLINGTON, Mass., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
August 04, 2014 07:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Reports Second Quarter 2014 Financial Results

BURLINGTON, Mass., Aug. 4, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases thought to be...
July 23, 2014 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Schedules Webcast and Conference Call for Second Quarter 2014 Financial Results

BURLINGTON, Mass., July 23, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases thought to be...